2023-08-07 Standards Vocab WG Meeting Notes

Date

Aug 7, 2023

Attendees

  • Attendee capture from zoom

Name

Organization

Role

Name

Organization

Role

Scott Campbell

UNMC

Co-Chair

Steering Committee member

Raj Dash

College of American Pathologists (CAP)

Co-Chair

Steering Committee member

Dan Rutz

Epic

Steering Committee member

Muktha Natrajan

CDC

 

Sandy Jones (Secondary)

CDC Cancer Surveillance

 

Anne Peruski (Secondary)

CDC

 

Andrea Pitkus

University of Wisconsin-Madison

Steering Committee member

Xavier Gansel

bioMérieux

Steering Committee member

Stan Huff

Graphite Health

Steering Committee member

John Snyder

NLM

Steering Committee member

Rob Hausam

Hausam Consulting

 

Marjorie Rollins

Regenstrief

Steering Committee member

Amy McCormick (secondary)

Epic

 

Nanguneri Nirmala

Tufts Medical Center

Steering Committee member

Mehdi Nassiri

Indiana University/Indiana University Health/Association for Molecular Pathology

Steering Committee member

Eza Hafeza

Regenstrief

Steering Committee member

Jim Case

Snomed International

Steering Committee member

Mary Kennedy

CAP

 

 

Discussion topics

Item

Notes

Item

Notes

Review of Purpose and Scope for the working group

  • Updated “Purpose” and “Scope”

Purpose

The work group will recommend use of vocabulary and associated standards in support of interoperability of laboratory results.  Interoperability of laboratory results is defined as machine level recognition of which results are comparable and trendable. Lab orders and metadata associated with the order (e.g. ask at order entry questions) would be addressed insofar as coding an IVD (LIVD) by manufacturers would be helpful in recognizing comparability of lab results.

Scope

Currently In-Scope:

  • Vocabulary standards (SNOMED CT, LOINC, UCUM)

  • Supporting messaging/transport standards (HL7 v2 and FHIR)

  • Supporting identifier standards (device identifiers [UDI], test kit identifiers [reagent/lot], specimen container identifiers, GS1 supply chain identifiers [inventory], [blood bank] product identifiers)

  • Supporting information and data models (data elements, pre vs post coordination, order level metadata [ask at order entry question responses], clinical information, procedure/method metadata [e.g. antibody, point-of-care vs routine, processing steps, etc.])

  • Any and all laboratory tests utilized for clinical care or public health in the USA today except direct access testing (FDA approved and laboratory developed tests [LDTs]).

Currently Out-of-Scope:

  • Billing coding systems (CPT, HCPCS, PLA)

  • Experimental and/or research-only tests.

  • Non-laboratory data.

  • Implementation guidance.

  • Policy and regulations.

  • Translation from other languages to English.

  • Direct access testing (DAT) / consumer performed testing.

 

Additional Notes

  • UDI - has device identifier and production identifier (instance or lot) - need to decide on which level

  • how many UDIs do you include in the results (for example urine analysis panel)

  • Include CPT, HCPCS etc? - make out of scope

  • what about ICD-10 code in DG1 segment - does that affect lab testing workflow?





Cloud Recording: Video Conferencing, Web Conferencing, Webinars, Screen Sharing

From Chat:

Andrea Pitkus, PhD, MLS(ASCP)CE, FAMIA. UW-Madison 1:47 PM
Here's an example of a simple hormone stimulation test where the stimulant is listed in the order naming and not the results: 140761: Cortisol, ACTH Stimulation | Labcorp
On the LIDR call, IHE LAW and HL7 were mentioned that would be part of this group (standards)

Xavier Gansel 1:52 PM
GS1 is used world wide

Andrea Pitkus, PhD, MLS(ASCP)CE, FAMIA. UW-Madison 1:59 PM
CPT® PLA Codes

Action items

Quick decisions not requiring context or tracking

For quick, smaller decisions that do not require extra context or formal tracking, use the “Add a decision…” function here.

Decisions requiring context or tracking

For decisions that require more context (e.g., documentation of discussion, options considered) and/or tracking, use the decision template to capture more information.